Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | AZN | AMGN | GILD | VRTX |
| Company | Blueprint Medicines Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 100.99 | 69.79 | 275.91 | 105.76 | 442.00 |
| High | 103.15 | 70.43 | 276.90 | 109.25 | 448.00 |
| Low | 96.15 | 69.56 | 274.28 | 105.76 | 440.81 |
| Last | 103.00 | 69.92 | 275.01 | 109.11 | 447.18 |
| Change | +1.79 | +0.23 | -0.84 | +2.95 | +6.52 |
| % Change | +1.76% | +0.33% | -0.30% | +2.78% | +1.48% |
| Volume | 448,900 | 4,295,100 | 2,188,600 | 10,712,000 | 1,510,600 |
| 20-Day Average Volume | 823,450 | 5,455,395 | 2,918,925 | 9,574,686 | 2,133,625 |
| Previous Close | 101.21 | 69.69 | 275.85 | 106.16 | 440.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 96.46 | 69.53 | 276.64 | 102.81 | 464.06 |
| 20-Day Raw Stochastic | 90.98% | 57.58% | 44.42% | 99.09% | 32.47% |
| 20-Day Relative Strength | 61.87% | 50.26% | 45.56% | 56.19% | 43.44% |
| Weighted Alpha | -0.37 | -10.67 | -12.39 | +60.79 | -5.20 |
| Today's Opinion | 56% Buy | 72% Sell | 72% Sell | 64% Buy | 56% Sell |
| Previous Opinion | 56% Buy | 56% Sell | 72% Sell | 40% Buy | 40% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 56% Sell | 40% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.62% since 05/13/25 | +3.25% since 05/13/25 | +1.69% since 05/13/25 | +7.57% since 05/13/25 | +3.51% since 05/13/25 |
| Low | 96.15 on 05/20/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 97.86 on 05/15/25 | 416.60 on 05/14/25 |
| High | 103.15 on 05/20/25 | 70.43 on 05/20/25 | 276.90 on 05/20/25 | 109.25 on 05/20/25 | 448.00 on 05/20/25 |
| 1-Month | |||||
| %Chg | +21.62% since 04/17/25 | +3.45% since 04/17/25 | -0.82% since 04/17/25 | +4.37% since 04/17/25 | -8.57% since 04/17/25 |
| Low | 83.27 on 04/22/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 104.86 on 05/02/25 | 72.69 on 05/06/25 | 292.00 on 04/30/25 | 109.25 on 05/20/25 | 510.77 on 04/30/25 |
| 3-Month | |||||
| %Chg | +9.17% since 02/20/25 | -6.22% since 02/20/25 | -7.69% since 02/20/25 | -0.84% since 02/20/25 | -6.90% since 02/20/25 |
| Low | 73.04 on 04/09/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 104.86 on 05/02/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +8.64% since 11/20/24 | +10.63% since 11/20/24 | -4.47% since 11/20/24 | +23.11% since 11/20/24 | -0.90% since 11/20/24 |
| Low | 73.04 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.07 on 11/21/24 | 377.85 on 12/19/24 |
| High | 118.25 on 01/27/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,536,667 | 216,125,920 | 148,326,208 | 132,055,504 | 113,160,168 |
| Shares Outstanding, K | 64,582 | 3,101,247 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 508,820,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -67,090,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 149,410,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | 500,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 0.83 | 0.40 | 0.51 | 0.26 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/01/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.93 | 13.12 | 13.24 | 0.00 |